De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Noxopharm Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Noxopharm has a total shareholder equity of A$5.5M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$6.8M and A$1.3M respectively.
Belangrijke informatie
0%
Verhouding schuld/eigen vermogen
AU$0
Schuld
Rente dekkingsratio | n/a |
Contant | AU$2.32m |
Aandelen | AU$5.50m |
Totaal verplichtingen | AU$1.29m |
Totaal activa | AU$6.78m |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: NOX's short term assets (A$4.8M) exceed its short term liabilities (A$1.2M).
Langlopende schulden: NOX's short term assets (A$4.8M) exceed its long term liabilities (A$42.2K).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: NOX is debt free.
Schuld verminderen: NOX currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: NOX has sufficient cash runway for more than 3 years based on its current free cash flow.
Voorspelling contante baan: NOX has sufficient cash runway for 1.9 years if free cash flow continues to grow at historical rates of 7.5% each year.